Advertisement

Reactions Weekly

, Volume 1746, Issue 1, pp 170–170 | Cite as

Regorafenib

Hand-foot skin reaction: case report
Case report
  • 14 Downloads

Reference

  1. Hwang S, et al. Regorafenib in patients with progression after sorafenib can be effective in both group (initial responder and primary nonresponder). Hepatology International 13 (Suppl. 1): S175 abstr. 862, Feb 2019. Available from: URL: http://doi.org/10.1007/s12072-019-09936-5 [abstract] - South Korea

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations